Cloning a human saliva-derived peptide for preventing kshv transmission

Journal of Investigative Dermatology

Volumn 132, Issue 6, 2012, Pages 1733-1735

  Grange, Philippe A ^a   Gressier, Ludivine ^a,b   Williams, John F ^c   Dyson, Ossie F ^c   Akula, Shaw M ^c   Dupin, Nicolas ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b AP HP ^*  (France)

^c EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; LACTOFERRIN; RECOMBINANT GREEN FLUORESCENT PROTEIN; RECOMBINANT PROTEIN; SALIVA PROTEIN; UNCLASSIFIED DRUG;

CARBOXY TERMINAL SEQUENCE; DISEASE SEVERITY; EPITHELIUM CELL; FIBROBLAST; HEPATITIS B VIRUS; HERPES VIRUS; HUMAN; KAPOSI SARCOMA; KAPOSI SARCOMA HERPES VIRUS; LETTER; MOLECULAR CLONING; NONHUMAN; OROPHARYNX; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVA; VIRION; VIRUS ENTRY; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 84862830791     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.30     Document Type: Letter

References (23)

1. Jin Y, Birlea SA, Fain PR et al. (2010b) Common variants in FOXP1 are associated with generalized vitiligo. Nat Genet 42:576-8
2. Mitchell MS, Hrel W, Groshen S (1992) Association of HLA phenotype with response to active specific immunotherapy of melanoma. J Clin Oncol 10:1158-64
3. Picardo M, Ta?̈eb A (eds) (2010) Vitiligo. New York: Springer
4. Quan C, Ren YQ, Xiang LH et al. (2010) Genomewide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC. Nat Genet 42:614-8
5. Skipper JC, Hendrickson RC, Gulden PH et al. (1996) An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. J Exp Med 183:527-34 (Pubitemid 26059516)
6. Song YH, Connor E, Li Y et al. (1994) The role of tyrosinase in autoimmune vitiligo. Lancet 344:1049-52 (Pubitemid 24310036)
7. Spritz RA (2010) The genetics of generalized vitiligo and an inverse relationship with malignant melanoma. Genome Med 2:78
8. Spritz RA, Strunk KM, Giebel LB et al. (1990) Detection of mutations in the tyrosinase gene in a patient with type IA oculocutaneous albinism. N Engl J Med 322:1724-8 (Pubitemid 20231531)
9. Toyofuku K, Wada I, Spritz RA et al. (2001) The molecular basis of oculocutaneous albinism type 1 (OCA1): sorting failure and degradation of mutant tyrosinases results in a lack of pigmentation. Biochem J 355:259-69 (Pubitemid 32397783)
10. Tripathi RK, Giebel LB, Strunk KM et al. (1991) A polymorphism of the human tyrosinase gene is associated with temperature-sensitive enzymatic activity. Gene Expr 1:103-10
11. Chang Y, Cesarman E, Pessin MS et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-9
12. Gallo RC (1998) The enigmas of Kaposi's sarcoma. Science 282:1837-9 (Pubitemid 28555252)
13. Grange PA, Marcelin AG, Calvez V et al. (2005) Salivary lactoferrin is recognized by the human herpesvirus-8. J Invest Dermatol 124:1249-58 (Pubitemid 40847413)
14. Groot F, Geijtenbeek TB, Sanders RW et al. (2005) Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN-gp120 interaction. J Virol 79:3009-15 (Pubitemid 40270580)
15. Li S, Zhou H, Huang G et al. (2009) Inhibition of HBV infection by bovine lactoferrin and iron-, zinc-saturated lactoferrin. Med Microbiol Immunol 198:19-25
16. Longhi G, Pietropaolo V, Mischitelli M et al. (2006) Lactoferrin inhibits early steps of human BK polyomavirus infection. Antiviral Res 72:145-52 (Pubitemid 44332569)
17. Marcelin AG, Gorin I, Morand P et al. (2004) Quantification of Kaposi's sarcoma-associated herpesvirus in blood, oral mucosa, and saliva in patients with Kaposi's sarcoma. AIDS Res Hum Retroviruses 20:704-8 (Pubitemid 39037499)
18. Marchetti M, Trybala E, Superti F et al. (2004) Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans. Virology 318:405-13 (Pubitemid 38236170)
19. Pauk J, Huang ML, Brodie SJ et al. (2000) Mucosal shedding of human herpesvirus 8 in men. N Engl J Med 343:1369-77
20. Plancoulaine S, Abel L, van Beveren M et al. (2000) Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet 356:1062-5
21. Vieira J, O'Hearn P, Kimball L et al. (2001) Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus. J Virol 75:1378-86 (Pubitemid 32094696)
22. Webster-Cyriaque J, Duus K, Cooper C et al. (2006) Oral EBV and KSHV infection in HIV. Adv Dent Res 19:91-5
23. Wu AM, Csako G, Herp A (1994) Structure, biosynthesis, and function of salivary mucins. Mol Cell Biochem 137:39-55 (Pubitemid 24328847)